ID   ICI 104A
AC   CVCL_WG91
SY   ICI 104 A; Institut du Cancer et d'Immunogenetique 104A
DR   Wikidata; Q94313507
RX   PubMed=4576460;
RX   PubMed=4890347;
RX   PubMed=5800808;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WG92 ! ICI 104B
OI   CVCL_WG93 ! ICI 104C
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
RX   PubMed=4576460;
RA   Le Borgne de Kaouel, Charles
RA   Billardon, Claude
RA   Dore, Jean-Francois
RA   Sylvestre, D.
RA   Marholev, L.
RA   Van Cong, Nguyen
RA   Weil, Dominique
RA   Picard, Jean-Yves
RA   Rebourcet, Regis
RA   Frezal, Jean
RT   "Hybridization of a human lymphoid leukaemia permanent cell line with
RT   mouse fibroblast cells.";
RL   Biomedicine 18:59-69(1973).
//
RX   PubMed=4890347; DOI=10.1038/222890a0;
RA   Belpomme, Dominique
RA   Le Borgne de Kaouel, Charles
RA   Ajuria, E.
RA   Jasmin, Claude
RA   Dore, Jean-Francois
RT   "Increase in antigenicity of permanent tissue culture lines ICI 101,
RT   ICI 104 and ICI 202 established from human leukaemic blood.";
RL   Nature 222:890-890(1969).
//
RX   PubMed=5800808;
RA   Le Borgne de Kaouel, Charles
RA   Belpomme, Dominique
RA   Dore, Jean-Francois
RA   Aubert, Christian
RA   Grandjon, Daniele
RT   "Obtaining and maintenance of permanent cell lines established from
RT   the blood of leukemic patients.";
RL   Rev. Fr. Etud. Clin. Biol. 14:530-532(1969).
//